The future of the global Breast Imaging Technologies Market looks promising with opportunities in the hospital and diagnostic center markets. The global breast imaging technologies market is expected to reach an estimated $8.83 billion by 2030 with a CAGR of 9.1% from 2024 to 2030. The major drivers for this market are rising prevalence of breast cancer, increasing demand for early diagnosis, and growing financial support from both private and government entities to enhance healthcare infrastructure development.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of
the most promising, high-growth opportunities for the breast imaging
technologies market by technology (ionizing breast imaging technology and non
ionizing breast imaging technology), end use (hospitals, diagnostic centers,
and others), and region (North America, Europe, Asia Pacific, and the Rest of
the World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and
why?
Q.4. What are the key
factors affecting market dynamics? What are the key challenges and business
risks in this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market
and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major
players in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market, ionizing
breast imaging technology and non-ionizing breast imaging technology are the
major segments of breast imaging technologies market by technology. Lucintel
forecasts that ionizing breast imaging technology is expected to witness higher
growth over the forecast period due to growing approvals for mammography and
screening procedures and technological advancements, including the development
of automated ultrasound systems. Within this market, hospitals will remain the
largest segment due to the rising preference of the people for hospital care,
growing investments in healthcare infrastructure development, and presence of
well-equipped operating and diagnostic rooms.
APAC is expected to
witness highest growth over the forecast period due to rising geriatric
population, growing cases of breast cancer, and increasing investments in
R&D activities in the region.
CANON, Fluidigm
Corporation, Fujifilm Holdings Corporation, General Electric, Hologic, koning
corporation, Koninklijke Philips N.V., Siemens, Smart Breast Corporation, and
Sonocine are the major suppliers in the breast imaging technologies market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
5. 3D Printing Medical
Device Market
8. Medical Lifting Sling
Market
9. Liquid Biopsy Market
10. Stretcher Market
No comments:
Post a Comment